The purpose of this study is to examine the proposed suicide preventive effects of lithium in a randomized controlled trial within a group of individuals with depressive disorders. The hypothesis being tested is that lithium treatment will significantly reduce the risk for another suicide attempt.
Several studies have shown that there is a significantly increased risk of suicide related mortality in patients with a positive history of suicide attempts. This study is the first prospective, randomized, double-blind, placebo controlled multi-center trial focussing on the proposed suicide preventive effects of lithium in patients with suicidal behavior but not suffering from bipolar disorder or recurrent major depressive disorder. Patients with a recent history of a suicide attempt are treated with lithium or placebo during a 12 month-period. The hypothesis is that lithium treatment will lead to a 50 % reduction of suicidal behavior.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
167
Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin
Berlin, Germany
Department of Psychiatry and Psychotherapy, Rheinische Friedrich-Willhelms-Universität
Bonn, Germany
Department of Psychiatry and Psychotherapy, Medizinische Fakultät der Technischen Universität Dresden
Dresden, Germany
Department of Psychiatry and Psychotherapy, Universitätsklinikum Schleswig-Holstein, Campus Luebeck
occurrence of attempted and completed suicides
Time frame: follow-up period of 1 year
Specific aspects of the suicide attempt/completed suicide
Time frame: follow-up period of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Lübeck, Germany
Department of Psychiatry and Psychotherapy, Klinikum Nuremberg Nord
Nuremberg, Germany